Oncology & Cancer

Immunotherapy for brain metastases: Where are we now?

Brain metastases are the most common type of brain tumors, affecting nearly 200,000 people in the United States each year. Once diagnosed, patients have a median survival of sic months. Immunotherapy, a type of cancer treatment ...

page 1 from 30